Investor's Business Daily on MSN
Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%
Merck said Saturday its new pill — a potential rival to Regeneron and Amgen — lowered stubbornly high cholesterol by almost ...
In recent days, Regeneron Pharmaceuticals announced detailed positive Phase 2 trial results for two novel factor XI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback